Alice Blue - 20 years of trust
    • ANT APP
    • ANT WEB
    • 1LyAlgos
    • 1lyOptions
    • TradingView
    • MTF
    • Insurance
    • IPO
    • Stocks
    • Mutual Funds
  • Partner with us
  • Trade School
  • Pricing

    • Pricing

    About Us

    • About Us

    Calculator

    • Calculators
    • Brokerage Calculator
    • MTF Calculator

    Resources

    • Blog
    • Webinars
    • Videos (YouTube)

    Updates

    • News
    • Trading Holidays
    • Cares
    • Media Coverage
    • Disclosures

    Support

    • Support
    • Refer & Earn
    CommunityCareers
Login

    Start Investing in Stocks₹0 Account Opening

    +91
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsPC JewellerVodafone IdeaIndian RenewableYes BankB.L.KashyapV2 RetailNip. India GoldPunjab Natl.BankBillionbrainsTata Gold ETFPhysicswallahTata Silver ETFBLS PolymersNippon I SilverIDFC First BankSuzlon EnergyBlue Cloud Soft.Motherson WiringKwality Wall's
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?
    Shares
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsPC JewellerVodafone IdeaIndian RenewableYes BankB.L.KashyapV2 RetailNip. India GoldPunjab Natl.BankBillionbrainsTata Gold ETFPhysicswallahTata Silver ETFBLS PolymersNippon I SilverIDFC First BankSuzlon EnergyBlue Cloud Soft.Motherson WiringKwality Wall's
    Indices
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    F&O
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Mutual Funds
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    Calculators
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    IPO
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?

    Company
    • About Us
    • Work with Us
    • Terms and Conditions
    • EKYC Guidelines
    • Contact Us
    • Cares
    Apps and Products
    • ANT APP
    • ANT WEB
    • 1LYOptions
    • Trade School
    • TradingView
    • 1LyAlgos
    Calculators
    • Calculators
    • SIP Calculator
    • Mutual Funds Return Calculator
    • Brokerage Calculator
    • RMS Live Updates
    • Term Coverage Calculator
    Important Links
    • Pricing
    • KYC Tracker
    • Market News
    • Global Indices
    • Gold Rate
    • Silver Rate
    • Trading Holidays

    Alice Blue
    3rd Floor, M.R.B.Arcade, No. 153/2,
    Bagalur Main Rd, Dwarka Nagar,
    Yelahanka, Bengaluru, Karnataka
    560063
    FacebookLinkedInX (Twitter)YouTubeInstagramWhatsapp

    ISO 27001:2022 Alice Blue is Certified Information Security Management System (ISMS)

    ISO 22301:2019 Alice Blue is Certified Business Continuity Management System (BCMS)

    DownloadsCircularsBank DetailsLearn
    Trade on TradingViewGet it on Google PlayDownload on the App Store

    Attention Investors!
    Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.

    Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. Pay 20% upfront margin of the transaction early to trade in the cash market segment. Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020, and NSE/INSP/45534 dated August 31, 2020, and other guidelines issued from time to time in this regard. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

    Corporate Office: No. 153/2, 3rd Floor, M.R.B.Arcade, Bagalur Main Road, Dwaraka Nagar, Yelahanka, Bengaluru – 560 063, Karnataka.
    Registered Office: Old No.56/2 ,New No.58, LIC Nagar, Vinayagar Kovil Street, Erode -8,Tamil Nadu– 638002.
    Alice Blue Financial Services (P) Ltd : NSE EQ | NSE FO | NSE CDS-90112 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : BSE EQ | BSE FO | BSE CD-6670 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : CDSL DP ID 12085300 DP SEBI REG : IN-DP-364-2018
    Alice Blue Financial Services (P) Ltd : MCX-56710 SEBI REG : INZ000156038

    COMPLIANCE OFFICER: SARAVANAN R | Mobile No: +91 91872 10670 | Email:[email protected]

    We hereby declare that we are doing PRO trading

    Procedure to file a complaint on SEBI SCORES / SMART ODR : Register on SEBI SCORES 2.0 / SMART ODR. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

    Click on the provided link to learn about the process for submitting a complaint on the ODR platform for resolving investor grievances. ODR Circular

    Investment in securities markets are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit.

    For queries regarding account opening or activation, email to accountactivation@aliceblueindia.com and for fund updates, email to funds@aliceblueindia.com

    Disclaimer: Attention investors:1) Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. 2) Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 3) Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. 4) For demat and trading account closure with AliceBlue, kindly visit https://aliceblueonline.com/support/closure-freezing-reactivation or “ANT APPLICATION” under your profile and click on Settings -> Account Closure section -> Initiate account closure.

    No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor’s account.

    Investors are requested to note that Alice Blue Financial Services Private Limited is permitted to receive money from investor through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Alice Blue Financial Services Private Limited is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker. Bank Details (Valid UPI FAQ).

    DND PolicyInvestor CharterLegal DocumentationPrivacy policyFeedbackAnnual ReturnsAdvisory for InvestorsE-votingMandatory Member Details

    Performance

    Historical price movement and trading activity

    Trading Data

    Today's High

    1712.9

    Today's Low

    1624

    Open

    1654.9

    Previous Close

    1708

    Volume

    160966

    Total Traded Value High

    269655115.2

    Technicals

    Price-based indicators and levels

    Indicators

    IndicatorValueSignal
    Relative Strength Index (RSI)+65.34Neutral
    MACD+34.66Bullish

    Support and Resistance Levels

    R31712.60
    R21676.80
    R11656.60
    S11600.60
    S21564.80
    S31544.60

    Moving Averages

    PeriodSMAEMA
    20D Moving Average1473.481496.23
    50D Moving Average1432.531459.81
    200D Moving Average1440.381440.38
    Fredun Pharmaceuticals Ltd

    Fredun Pharmaceuticals Ltd

    NSE: FREDUN | BSE: 539730
    ₹1708+71.60 (4.38%)
    BuySell

    News

    Fredun Pharmaceuticals' board reviewed a monitoring report for the quarter ended September 30, 2026

    14 Nov 2026

    Fredun Pharmaceuticals Limited informed the BSE Limited that its Board of Directors met on Saturday, November 14, 2026, at 03:00 P.M. and noted the Monitoring Agency Report for the quarter ended September 30, 2026.

    Fredun Pharmaceuticals confirms Rs 128.78 crore preferential issue use, despite reporting observations

    14 Nov 2026

    Fredun Pharmaceuticals Limited reported no deviation or variation in the utilization of Rs 128.78 crore raised through a preferential issue during the quarter ended September 30, 2026, according to a regulatory filing. Care Ratings Limited, the monitoring agency, noted observations regarding the reporting and reconciliation of fund utilization, classification of balances, and verification of funds, but the company maintains that the proceeds have been utilized for the objects approved by shareholders, with differences arising from varying treatments of Cash Credit account balances and reporting methods.

    Fredun Pharmaceuticals allots shares to warrant holders following board meeting on October 3, 2026

    5 Oct 2026

    Fredun Pharmaceuticals Limited announced the allotment of 1,82,400 equity shares with a face value of Rs 10 each to warrant holders following the conversion of 60,800 warrants, as per a board meeting held on October 3, 2026. The allotment is linked to convertible warrants initially issued on December 29, 2025, and adjusted after the company’s 1:2 bonus issue, with a balance consideration paid by the warrant holders. The company also disclosed that ten investors received the allotted shares, with Rashmi Jain and Girdhari T Jaisinghani each receiving 4,000 shares.

    Fredun Pharmaceuticals allotted shares to warrant holders following conversion and shareholder approval

    4 Oct 2026

    Fredun Pharmaceuticals Limited announced the allotment of 1,82,400 equity shares with a face value of Rs 10 each to warrant holders following the conversion of 60,800 warrants, as approved by shareholders on October 22, 2025. The allotment, made on October 3, 2026, occurred after warrant holders paid the remaining consideration and exercised their conversion rights, with the entitlement adjusted after a 1:2 bonus issue, resulting in three equity shares for each outstanding warrant.

    Fredun Pharmaceuticals allotted shares to warrant holders following conversion and shareholder approval

    3 Oct 2026

    Fredun Pharmaceuticals Limited announced the allotment of 1,82,400 equity shares with a face value of Rs 10 each to warrant holders following the conversion of 60,800 warrants, as approved by shareholders on October 22, 2025. The allotment, made on October 3, 2026, occurred after warrant holders paid the remaining consideration and exercised their conversion rights, with the entitlement adjusted after a 1:2 bonus issue, resulting in three equity shares for each outstanding warrant.

    Showing 1–5 of 15

    Insider Activity

    Daulat MedhoraPromoter & Director
    Acquired
    40000
    Shares Worth
    ₹5,00,00,000
    Reported On13 Apr 2026
    ModeConversion of security
    FREDUN MEDHORAPromoter & Director
    Acquired
    106668
    Shares Worth
    ₹13,33,35,000
    Reported On26 Mar 2026
    ModeConversion of security
    Fredun MedhoraPromoter & Director
    Acquired
    19072
    Shares Worth
    ₹1,89,99,526
    Reported On22 Sept 2023
    ModeAllotment
    DAULAT MEDHORAPromoter & Director
    Acquired
    18068
    Shares Worth
    ₹1,79,99,342
    Reported On25 Aug 2023
    ModeAllotment
    Nariman MedhoraPromoter & Director
    Acquired
    144515
    Shares Worth
    ₹6,09,99,782
    Reported On25 Nov 2021
    ModeAllotment
    Daulat MedhoraPromoter & Director
    Acquired
    52120
    Shares Worth
    ₹2,19,99,852
    Reported On25 Nov 2021
    ModeAllotment
    Trade now

    Overview

    Pharmaceuticals - Indian - FormulationsNSE / BSE

    Incorporated in 1987 as a Private Limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a Public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems. The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind. In Apr.'96, the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda & Sri Lanka. In 2013, Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015, three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line, with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category. In FY 2024, Company launched over 110 products under the Fredun Gx brand in India, including Anti-Diabetics, Anti-Hypertensives, Anti-biotics & Anti-fungal. During FY 2025 a second Italian Tube Filling Machine and two Automatic Carton Packaging Machines have been installed. Company acquired One Pet Stop Pvt Ltd, adding grooming services and access to over 4,000 pet owners. Fredun launched Freossi Tone+ (for lactation and milk quality) and Freossi Power (for joint health and mobility), targeting livestock like cows, buffaloes, horses, and cattle in 2025 Fredun Retail Pvt Ltd. was incorporated as subsidiary of the Company effective on February 4, 2025. Company has developed and launched many new molecules like antihypertensive, antidiabetic, ARVs and even narcotics in FY26.

    Fundamentals

    Financial strength and ownership structure

    Valuation & Ratios

    Market Capitalisation

    ₹914.92

    Price to Book (PB)

    3.46

    Price to Earnings (PE)

    28.05

    Return on Equity (ROE)

    15.55%

    Earnings Per Share (EPS)

    59.61

    Dividend Yield

    0.04%

    Financial Performance

    165.44
    119.40
    143.59
    159.93
    210.41
    227.76
    265.85
    Mar
    '25
    Jun
    '25
    Sep
    '25
    Dec
    '25
    Mar
    '26
    Jun
    '26
    Sep
    '26

    Shareholding Pattern

    44.17%
    44.57%
    44.57%
    43.62%
    Mar
    '26
    Jun
    '26
    Jul
    '26
    Sep
    '26